Purchase Order 75N91020P00708

<p>The National Cancer Institute awarded a purchase order to Advanced Cell Diagnostics, Inc. for laboratory testing with a ceiling value of $19,772.00 and an award date of August 13, 2020. The order carries no set-aside designation and firm fixed pricing. Work is performed in Newark, California. The purchase order has an ultimate completion date of September 30, 2020.</p>

<p>The National Cancer Institute awarded a purchase order to Advanced Cell Diagnostics, Inc. valued at $13,814.40 on September 17, 2020, with completion targeted for November 26, 2020. The order carries firm fixed pricing with no small business set-aside. Performance occurs in Newark, California. The purchase order procures RNA detection technologies and related diagnostic products from Advanced Cell Diagnostics' RNAscope platform for cancer research support.</p>

The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $17,696 firm fixed price purchase order to Advanced Cell Diagnostics, Inc. of Newark, California for lab testing services. As the prime contractor, Advanced Cell Diagnostics will provide the requested testing services to the agency. Advanced Cell Diagnostics is a subsidiary of Bio-Techne Corporation, located in Newark. The award does not have a set-aside designation. The contract has a...

The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $13,128 purchase order to Advanced Cell Diagnostics, Inc., doing business as ACD, for reagents. ACD is a division of Bio-Techne Corporation, doing business as Bio-Techne. The firm fixed price order runs from July 31, 2023 through August 31, 2023 for delivery to ACD's Newark, California facility. No additional details were provided on the original solicitation, major subcontractors, or...

The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $16,580 firm fixed price purchase order to Advanced Cell Diagnostics, Inc. for RNAScope under contract number 1187802. Advanced Cell Diagnostics, Inc. will deliver its cell diagnostics technology from its Newark, California location under the eight-month contract ending in March 2024. As part of the National Institutes of Health's medical research efforts, this contract provides RNAScope, a...

The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $13,507.60 firm fixed price purchase order to Advanced Cell Diagnostics, Inc. for advanced cell diagnostics services. Advanced Cell Diagnostics, Inc. will perform as the prime contractor, with its parent company listed as Bio-Techne Corporation. The contract period of performance is from November 13, 2023 through January 5, 2024. It is presumed Advanced Cell Diagnostics, Inc. will provide their...

<p>The National Cancer Institute awarded a purchase order to Creative Biolabs Inc. for $19,800.00 in lab testing services, effective September 16, 2020, with completion targeted for December 20, 2020. Work is performed in East Yaphank, New York under firm fixed-price terms. No small business set-aside applies to this order.</p>

<p>The National Cancer Institute awarded a purchase order to 10X Genomics, Inc. valued at $10,718.00 on June 25, 2020, with completion scheduled for July 24, 2020. Performance takes place in Pleasanton, California. The order is firm fixed price with no set-aside designation. The source does not specify the items or services being procured.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for biological kits valued at $14,923.40 on August 24, 2020, with an ultimate completion date of September 23, 2020. Place of performance is Carlsbad, California. The order carries firm fixed pricing with no set-aside designation.</p>

<p>The National Cancer Institute awarded a purchase order to Adaptive Biotechnologies Corporation for $20,850 on September 11, 2020, with final completion on December 11, 2020. The order covers laboratory testing services on a firm fixed-price basis with no set-aside designation. Work is performed in Bethesda, Maryland.</p>